San Francisco— Abbott Laboratories said it is issuing a Class I recall of its Architect Stat Troponin-1 Immunoassay after a small number of clinical laboratories reported inconsistent or invalid test results at very low levels. The test is used by doctors in testing diagnosing damage to the heart and/or a heart attack in people who have had chest pain. For more information, please visit:
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Architect
